Cite

HARVARD Citation

    Kuemmerle-Deschner, J. et al. (2015). Canakinumab treat-to target strategies increase complete response rate in CAPS. Pediatric rheumatology online journal. 13 (1), p. 1. [Online]. 
  
Back to record